Divis Laboratories Ltd | DIVI - Pre Tax Profit


Divis Laboratories Ltd reported INR9.63B in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
Alaunos Therapeutics USD -7.84M 633K Dec/2023
Aurobindo Pharma INR 12.91B 1.13B Mar/2026
Avita Medical AUD -11.64M 12.13M Dec/2025
Dianthus Therapeutics USD -64.43M 27.67M Dec/2025
Divis Laboratories Ltd INR 9.63B 1.09B Mar/2026
Ionis Pharmaceuticals USD -93M 135M Mar/2026
IQVIA Holdings USD 6.22B 5.68B Mar/2026
Lupin INR 19.49B 583.6M Dec/2025
Moderna USD -799M 612M Dec/2025
Organon & Co USD -148M 391M Dec/2025
Revvity USD 91.56M 35.88M Dec/2025
Tectonic Therapeutic USD -18.97M 63K Dec/2025
Tilray USD -39.96M 39.19M Sep/2025
Viatris USD -343M 335.1M Dec/2025
Xeris Pharmaceuticals USD 11.08M 10.46M Dec/2025